Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?
- PMID: 33027083
- PMCID: PMC9205618
- DOI: 10.14309/ajg.0000000000000954
Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?
Abstract
Introduction: The American Association for the Study of Liver Diseases recommends hepatitis D virus (HDV) screening in certain high-risk groups; however, the effectiveness is unknown.
Methods: A study of North American patients with hepatitis B (HBV) referred to the NIH was performed to identify risk factors associated with HDV infection. Active HDV was "confirmed" by serum HDV RNA or histologic HDV antigen staining.
Results: Six hundred fifty-two were studied, of which 91 were HDV "confirmed." Independent risk factors for HDV included: intravenous drug users, HBV-DNA <2,000 IU/mL, alanine aminotransferase >40 U/L, and HDV endemic country of origin.
Disussion: North American patients with HBV and significant risk factors should be screened for HDV.
Copyright © 2020 by The American College of Gastroenterology.
Conflict of interest statement
References
-
- Sureau C. The role of the HBV envelope proteins in the HDV replication cycle. Curr Top Microbiol Immunol 2006;307:113–31. - PubMed
-
- Manesis EK, Vourli G, Dalekos G, et al. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study. J Hepatol 2013;59:949–56. - PubMed
-
- Beguelin C, Moradpour D, Sahli R, et al. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. J Hepatol 2017;66:297–303. - PubMed
-
- Chen HY, Shen DT, Ji DZ, et al. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut 2018. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
